Renalytix Files Registration Statement on Behalf of Selling Shareholders
Renalytix (RNLX) filed Wednesday a registration statement for the potential offering of up to 26.8 million ordinary shares, including in the form of American depositary shares, by certain selling stockholders.
The company will not receive any proceeds from the secondary offering.